Muscarinic cholinergic influences in memory consolidation

Neurobiology of Learning and Memory

Volumn 80, Issue 3, 2003, Pages 178-193

  Power, Ann E ^a   Vazdarjanova, Almira ^b   McGaugh, James L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Acetylcholine; Basolateral amygdala; Multiple memory systems; Nucleus basalis magnocellularis

Indexed keywords

ACETYLCHOLINE; MUSCARINIC RECEPTOR;

AMYGDALOID NUCLEUS; BASOLATERAL MEMBRANE; BRAIN CORTEX; BRAIN FUNCTION; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; COGNITION; CONFERENCE PAPER; CORPUS STRIATUM; HIPPOCAMPUS; HUMAN; LEARNING; MEMORY; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NEUROMODULATION; TRAINING;

EID: 0141745509     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7427(03)00086-8     Document Type: Conference Paper

References (164)

1. Acquas E., Wilson C., Fibiger H.C. Pharmacology of sensory stimulation-evoked increases in frontal cortical acetylcholine release. Neuroscience. 85:1998;73-83.
2. Anagnostaras S.G., Murphy G.G., Hamilton S.E., Mitchell S.L., Rahnama N.P., Nathanson N.M., Silva A.J. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nature Neuroscience. 6:2003;51-58.
3. Aramakis V.B., Bandrowski A.E., Ashe J.H. Activation of muscarinic receptors modulates NMDA receptor-mediated responses in auditory cortex. Experimental Brain Research. 113:1997;484-496.
4. Auerbach J., Segal M. A novel cholinergic induction of long-term potentiation in rat hippocampus. Journal of Neurophysiology. 72:1994;2034-2040.
5. Baratti C.M., Huygens P., Mino J., Merlo A., Gardella J. Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice. Psychopharmacology. 64:1979;85-88.
6. Baratti C.M., Introini I.B., Huygens P. Possible interaction between central cholinergic muscarinic and opioid peptidergic systems during memory consolidation in mice. Behavioral Neural Biology. 40:1984;155-169.
7. Barefoot H.C., Baker H.F., Ridley R.M. Crossed unilateral lesions of temporal lobe structures and cholinergic cell bodies impair visual conditional and object discrimination learning in monkeys. European Journal of Neuroscience. 15:2002;507-516.
8. Barefoot H.C., Baker H.F., Ridley R.M. Synergistic effects of unilateral immunolesions of the cholinergic projections from the basal forebrain and contralateral ablations of the inferotemporal cortex and hippocampus in monkeys. Neuroscience. 98:2000;243-251.
9. Barros D.M., Pereira P., Medina J.H., Izquierdo I. Modulation of working memory and of long- but not short-term memory by cholinergic mechanisms in the basolateral amygdala. Behavioural Pharmacology. 13:2002;163-167.
10. Bartus R.T., Reginald L., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-414.
11. Bear M., Singer W. Modulation of visual cortical plasticity by acetylcholine and noradrenaline. Nature. 320:1986;172-176.
12. Beninger R.J., Kuhnemann S., Inglis J.L., Jhamandas K., Boegman R.J. Mnemonic deficits in the double Y-maze are related to the effects of nucleus basalis injections of ibotenic and quisqualic acid on choline acetyltransferase in the rat amygdala. Brain Research Bulletin. 35:1994;147-152.
13. Berger-Sweeney J., Stearns N.A., Frick K.M., Beard B., Baxter M.G. Cholinergic basal forebrain is critical for social transmission of food preferences. Hippocampus. 10:2000;729-738.
14. Bianchin M., Mello e Souza T., Medina J.H., Izquierdo I. The amygdala is involved in the modulation of long-term memory, but not in working or short-term memory. Neurobiology of Learning and Memory. 71:1999;127-131.
15. Biesold D., Inanami O., Sato A., Sato Y. Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats. Neuroscience Letters. 98:1989;39-44.
16. Bliss T., Collingridge G. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
17. Blitzer R., Landau E. Cholinergic stimulation enhances long-term potentiation in the CA1 region of rat hippocampus. Neuroscience Letters. 119:1990;207-210.
18. Breen R.A., McGaugh J.L. Facilitation of maze learning with posttrial injections of picrotoxin. Journal of Comparative and Physiological Psychology. 54:1961;498-501.
19. Buccafusco J.J., Terry A.V. Jr. Multiple central nervous system targets for eliciting beneficial effects on memory and cognition. Journal of Pharmacology and Experimental Therapeutics. 295:2000;438-446.
20. Bureš J., Bohdanecký Z., Weiss T. Physostigmine induced hippocampal theta activity and learning in rats. Psychopharmacologia. 3:1962;254-263.
21. Burešová O., Bureš J., Bohdanecký Z., Weiss T. Effect of atropine on learning, extinction, retention and retrieval in rats. Psychopharmacologia. 5:1964;255-263.
22. Burgard E., Sarvey J. Muscarinic receptor activation facilitates the induction of long-term potentiation (LTP) in the rat dentate gyrus. Neuroscience Letters. 116:1990;34-39.
23. Cahill L., McGaugh J.L. NMDA-induced lesions of the amygdaloid complex block the retention-enhancing effect of posttraining epinephrine. Psychobiology. 19:1991;206-210.
24. Cangioli I., Baldi E., Mannaioni P.F., Bucherelli C., Blandina P., Passani M.B. Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release. European Journal of Neuroscience. 16:2002;521-528.
25. Cardo B. Action de l'amphétamine dextrogyre et de l'eserine sur un conditionnement de fuite et sur les phénomènes de discrimination. Journal of Physiology (Paris). 5:1959;845-860.
26. Carlton P.L. Cholinergic mechanisms in the control of behavior by the brain. Psychology Review. 70:1963;19-39.
27. Casamenti F., Deffenu G., Abbamondi A., Pepeu G. Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. Brain Research Bulletin. 16:1986;689-695.
28. Cox C., Metherate R., Ashe J. Modulation of cellular excitability in neocortex: Muscarinic receptor and second messenger-mediated actions of acetylcholine. Synapse. 16:1994;123-136.
29. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
30. Dalmaz C., Introini-Collison I.B., McGaugh J.L. Noradrenergic and cholinergic interactions in the amygdala and the modulation of memory storage. Behavioral Brain Research. 58:1993;167-174.
31. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. ii:1976;1403.
32. Delacour J., Houcine O., Costa J. Evidence for a cholinergic mechanism of learned changes in the responses of barrel field neurons of the awake and undrugged rat. Neuroscience. 34:1990;1-8.
33. Drachman D.A., Leavitt J. Human memory and the cholinergic system. Archives in Neurology. 30:1974;113-121.
34. Dunnett S.B., Whishaw I.Q., Jones G.H., Bunch S.T. Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience. 20:1987;653-669.
35. Dutar P., Nicoll R. Classification of muscarinic responses in hippocampus in terms of receptor subtype and second-messenger systems: Electrophysiological studies in vitro. Journal of Neuroscience. 8:1988;4214-4224.
36. Easton A., Ridley R.M., Baker H.F., Gaffan D. Unilateral lesions of the cholinergic basal forebrain and fornix in one hemisphere and inferior temporal cortex in the opposite hemisphere produce severe learning impairments in rhesus monkeys. Cerebral Cortex. 12:2002;729-736.
37. Farr S.A., Uezu K., Creonte T.A., Flood J.F., Morley J.E. Modulation of memory processing in the cingulate cortex of mice. Pharmacology, Biochemistry and Behavior. 65:2000;363-368.
38. Ferreira G., Meurisse M., Gervais R., Ravel N., Levy F. Extensive immunolesions of basal forebrain cholinergic system impair offspring recognition in sheep. Neuroscience. 106:2001;103-116.
39. Fine A., Hoyle C., Maclean C.J., Levatte T.L., Baker H.F., Ridley R.M. Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys. Neuroscience. 81:1997;331-343.
40. Friedman J.I., Adler D.N., Davis K.L. The role of norepinephrine in the pathophysiology of cognitive disorders: Potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biological Psychiatry. 46:1999;1243-1252.
41. Gottfries C.G., Adolfsson R., Aquilonius S.M., Carlsson A., Eckernas S.A., Nordberg A., Oreland L., Svennerholm L., Wiberg A., Winblad B. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiology of Aging. 4:1983;261-271.
42. Gulat-Marnay C., Lafitte A., Arrang J.M., Schwartz J.C. Regulation of histamine release and synthesis in the brain by muscarinic receptors. Journal of Neurochemistry. 52:1989;248-254.
43. Gutiérrez H., Gutiérrez R., Ramírez-Trejo L., Silva-Gandarias R., Ormsby C.E., Miranda M.I., Bermúdez-Rattoni F. Redundant basal forebrain modulation in taste aversion memory formation. Journal of Neuroscience. 19:1999;7661-7669.
44. Gutiérrez H., Gutiérrez R., Silva-Gandarias R., Estrada J., Miranda M.I., Bermúdez-Rattoni F. Differential effects of 192IgG-saporin and NMDA-induced lesions into the basal forebrain on cholinergic activity and taste aversion memory formation. Brain Research. 834:1999;136-141.
45. Gutiérrez H., Miranda M.I., Bermúdez-Rattoni F. Learning impairment and cholinergic deafferentation after cortical nerve growth factor deprivation. Journal of Neuroscience. 17:1997;3796-3803.
46. Gutiérrez R., Téllez L.A., Bermúdez-Rattoni F. Blockade of cortical muscarinic but not NMDA receptors prevents a novel taste from becoming familiar. European Journal of Neuroscience. 17:2003;1556-1562.
47. Hasselmo M.E. Neuromodulation: Acetylcholine and memory consolidation. Trends in Cognitive Sciences. 3:1999;351-359.
48. Hatfield T., McGaugh J.L. Norepinephrine infused into the basolateral amygdala posttraining enhances retention in a spatial water maze task. Neurobiology of Learning and Memory. 71:1999;232-239.
49. Heckers S., Mesulam M.-M. Two types of cholinergic projections to the rat amygdala. Neuroscience. 60:1994;383-397.
50. Herz A. Drugs and the conditioned avoidance response. International Review of Neurobiology. 2:1960;229-277.
51. Hunter B., Zornetzer S.F., Jarvik M.E., McGaugh J.L. Modulation of learning and memory: Effects of drugs influencing neurotransmitters. Iversen L., Iversen S., Snyder S. Handbook of psychopharmacology. Drugs, Neurotransmitters, and Behavior. Vol. 8:1977;531-577 Plenum Press, New York.
52. Introini I.B., Baratti C.M. The impairment of retention induced by beta-endorphin in mice may be mediated by a reduction of central cholinergic activity. Behavioral and Neural Biology. 41:1984;152-163.
53. Introini-Collison I.B., Arai Y., McGaugh J.L. Stria terminalis lesions attenuate the effects of posttraining oxotremorine and atropine on retention. Psychobiology. 17:1989;397-401.
54. Introini-Collison I.B., Dalmaz C., McGaugh J.L. Amygdala beta-noradrenergic influences on memory storage involve cholinergic activation. Neurobiology of Learning and Memory. 65:1996;57-64.
55. Ito T., Miura Y., Kadokawa T. Physostigmine induces in rats a phenomenon resemblings long-term potentiation. European Journal of Pharmacology. 156:1988;351-359.
56. Izquierdo I., da Cunha C., Rosat R., Jerusalinsky D., Ferreira M.B., Medina J.H. Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat. Behavioral and Neural Biology. 58:1992;16-26.
57. Izquierdo I., Quillfeldt J.A., Zanatta M.S., Quevedo J., Schaeffer E., Schmitz P.K., Medina J.H. Sequential role of hippocampus and amygdala, entorhinal cortex and parietal cortex in formation and retrieval of memory for inhibitory avoidance in rats. European Journal of Neuroscience. 9:1997;786-793.
58. Jerusalinsky D., Cervenansky C., Walz R., Bianchin M., Izquierdo I. A peptide muscarinic toxin from the Green Mamba venom shows agonist-like action in an inhibitory avoidance learning task. European Journal of Pharmacology. 240:1993;103-105.
59. Jerusalinsky D., Kornisiuk E., Bernabeu R., Izquierdo I., Cervenansky C. Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions. Toxicon. 33:1995;389-397.
60. Juliano S., Ma W., Bear M., Eslin D. Cholinergic manipulation alters stimulus-evoked metabolic activity in cat somatosensory cortex. Journal of Comparative Neurology. 297:1990;106-120.
61. Kesner R.P., Crutcher K.A., Omana H. Memory deficits following nucleus basalis magnocellularis lesions may be mediated through limbic, but not neocortical, targets. Neuroscience. 38:1990;93-102.
62. Kirkwood A., Rozas C., Kirkwood J., Perez F., Bear M. Modulation of long-term synaptic depression in visual cortex by acetylcholine and norepinephrine. Journal of Neuroscience. 19:1999;1599-1609.
63. Kita H., Kitai S.T. Amygdaloid projections to the frontal cortex and the striatum in the rat. Journal of Comparative Neurology. 298:1990;40-49.
64. Kopf S., Buchholzer M., Hilgert M., Loffelholz K., Klein J. Glucose plus choline improves passive avoidance behavior and increases hippocampal acetylcholine release in mice. Neuroscience. 103:2001;365-371.
65. Kopf S.R., Boccia M.M., Baratti C.M. AF-DX 116, a presynaptic muscarinic receptor antagonist, potentiates the effects of glucose and reverses the effects of insulin on memory. Neurobiology of Learning and Memory. 70:1998;305-313.
66. Koyama T., Nakajima Y., Fujii T., Kawashima K. Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats. Neuroscience Letters. 265:1999;33-36.
67. Krech D., Rosenzweig M.R., Bennett E.C., Krueckel B. Enzyme concentrations in the brain and adjustive behavior patterns. Science. 120:1954;994-996.
68. Kurosawa M., Sato A., Sato Y. Stimulation of the nucleus basalis of Meynert increases acetylcholine release in the cerebral cortex in rats. Neuroscience Letters. 98:1989;45-50.
69. Levkovitz Y., Segal M. Acetylcholine mediates the effects of fenfluramine on dentate granule cell excitability in the rat. European Journal of Pharmacology. 264:1994;279-284.
70. Liang K.C., McGaugh J.L., Yao H.Y. Involvement of amygdala pathways in the influence of post-training intra-amygdala norepinephrine and peripheral epinephrine on memory storage. Brain Research. 508:1990;225-233.
71. Lindefors N., Boatell M.L., Mahy N., Persson H. Widespread neuronal degeneration after ibotenic acid lesioning of cholinergic neurons in the nucleus basalis revealed by in situ hybridization. Neuroscience Letters. 135:1992;262-264.
72. Liu Y., Jia W., Gu Q., Cynader M. Involvement of muscarinic acetylcholine receptors in regulation of kitten visual cortex plasticity. Developmental Brain Research. 79:1994;63-71.
73. Malin, E. L., & McGaugh, J. L. (2003). Basolateral amygdala lesions block the memory enhancing effect of oxotremorine infused into the rostral anterior cingulated dortex after inhibitory avoidance training. In 33rd Society for neuroscience abstracts. Washington, DC: Society for Neuroscience.
74. Malin, E. L., Roozendaal, B., & McGaugh, J. L. (2002). Post-trianing infusions of oxotremorine into the rostral anterior cingulated cortex enhance inhibitory avoidance retention. In 32nd Society for neuroscience abstracts no. 379.4. Washington, DC: Society for Neuroscience.
75. Mallet P.E., Beninger R.J., Flesher S.N., Jhamandas K., Boegman R.J. Nucleus basalis lesions: Implication of basoamygdaloid cholinergic pathways in memory. Brain Research Bulletin. 36:1995;51-56.
76. Mann D.M., Yates P.O., Hawkes J. The noradrenergic system in Alzheimer and multi-infarct dementias. Journal of Neurology, Neurosurgery and Psychiatry. 45:1982;113-119.
77. Massey P., Bhabra G., Cho K., Brown M., Bashir Z. Activation of muscarinic receptors induces protein synthesis-dependent long-lasting depression in the perirhinal cortex. European Journal of Neuroscience. 14:2001;145-152.
78. McCormic D., Prince D. Mechanisms of action of acetylcholine in the guinea-pig cerebral cortex in vitro. Journal of Physiology. 375:1986;169-194.
79. McGaugh J.L., Introini-Collison I.B., Cahill L.F., Castellano C., Dalmaz C., Parent M.B., Williams C.L. Neuromodulatory systems and memory storage: Role of the amygdala. Behavioral Brain Research. 58:1993;81-90.
80. McGaugh J.L., Petrinovich L.F. Effects of drugs on learning and memory. International Review of Neurobiology. 8:1965;139-196.
81. McGaugh J.L. Time-dependent processes in memory storage. Science. 153:1966;1351-1358.
82. McGaugh J.L., Herz M.J. Memory consolidation. 1972;204 Albion Publishing Company, San Francisco.
83. McGaugh J.L. Dissociating learning and performance: Drug and hormone enhancement of memory storage. Brain Research Bulletin. 23:1989;339-345.
84. McGaugh J.L., Izquierdo I. The contribution of pharmacology to research on the mechanisms of memory formation. Trends in Pharmacological Sciences. 21:2000;208-210. McGaugh, J. L. (1959). Some neurochemical factors in learning. Unpublished Ph.D. dissertation, University of California, Berkeley.
85. McGaugh, J. L. (1959). Some neurochemical factors in learning. Unpublished Ph.D. dissertation, University of California, Berkeley.
86. McGaugh J.L. Memory - a century of consolidation. Science. 287:2000;248-251.
87. McGaugh J.L., McIntyre C.K., Power A.E. Amygdala modulation of memory consolidation: Interaction with other brain systems. Neurobiology of Learning and Memory. 78:2002;539-552. doi 10.1006/nlme.2002.4082.
88. McIntyre C.K., Marriott L.K., Gold P.E. Patterns of brain acetylcholine release predict individual differences in preferred learning strategies in rats. Neurobiology of Learning and Memory. 79:2003;177-183.
89. McIntyre C.K., Power A.E., Roozendaal B., McGaugh J.L. Role of the basolateral amygdala in memory consolidation. Shinnick-Gallagher P., Pitkanen A., Shekhar A., Cahill L. The amygdala in brain function: Basic and clinical approaches. Annals of the New York Academy of Sciences. Vol. 985:2003;1-21.
90. McIntyre C.K., Ragozzino M.E., Gold P.E. Intra-amygdala infusions of scopolamine impair performance on a conditioned place preference task but not a spatial radial maze task. Behavioural Brain Research. 95:1998;219-226.
91. McLin D.E. III, Miasnikov A.A., Weinberger N.M. Induction of behavioral associative memory by stimulation of the nucleus basalis. Proceedings of the National Academy of Sciences of the United States of America. 99:2002;4002-4007.
92. McLin III D.E., Miasnikov A.A., Weinberger N.M. The effects of electrical stimulation of the nucleus basalis on the electroencephalogram, heart rate, and respiration. Behavioral Neuroscience. 116:2002;795-806.
93. Metherate R., Ashe J. Basal forebrain stimulation modifies auditory cortex responsiveness by an action at muscarinic receptors. Brain Research. 559:1991;163-167.
94. Miasnikov A., McLin III D., Weinberger N. Muscarinic dependence of nucleus basalis induced conditioned receptive field plasticity. Neuroreport. 12:2001;1537-1542.
95. Miranda M.I., Bermúdez-Rattoni F. Reversible inactivation of the nucleus basalis magnocellularis induces disruption of cortical acetylcholine release and acquisition, but not retrieval, of aversive memories. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;6478-6482.
96. Mohs R.C., Davis B.M., Greenwald B.S., Mathe A.A., Johns C.A., Horvath T.B., Davis K.L. Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies. Journal of the American Geriatric Society. 33:1985;749-757.
97. Moore H., Fadel J., Sarter M., Bruno J.P. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience. 88:1999;811-822.
98. Mouton P.R., Meyer E.M., Arendash G.W. Intracortical AF64A: Memory impairments and recovery from cholinergic hypofunction. Pharmacology, Biochemistry and Behavior. 32:1989;841-848.
99. Mouton P.R., Meyer E.M., Dunn A.J., Millard W., Arendash G.W. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions. Brain Research. 444:1988;104-118.
100. Murray C.L., Fibiger H.C. Learning and memory deficits after lesions of the nucleus basalis magnocellularis: Reversal by physostigmine. Neuroscience. 14:1985;1025-1032.
101. Naor C., Dudai Y. Transient impairment of cholinergic function in the rat insular cortex disrupts the encoding of taste in conditioned taste aversion. Behavioral Brain Research. 79:1996;61-67.
102. Oh J., Edwards R., Woolf N. Choline acetyltransferase mRNA plasticity with Pavlovian conditioning. Experimental Neurology. 140:1996;95-99.
103. Orsetti M., Casamenti F., Pepeu G. Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior. Brain Research. 724:1996;89-96.
104. Packard M.G., Teather L.A. Amygdala modulation of multiple memory systems: Hippocampus and caudate-putamen. Neurobiology of Learning and Memory. 69:1998;163-203.
105. Packard M.G., Cahill L., McGaugh J.L. Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes. Proceedings of the National Academy of Sciences of the United States of America. 91:1994;8477-8481.
106. Packard M.G., Introini-Collison I., McGaugh J.L. Stria terminalis lesions attenuate memory enhancement produced by intracaudate nucleus injections of oxotremorine. Neurobiology of Learning and Memory. 65:1996;278-282.
107. Page K.J., Sirinathsinghji D.J., Everitt B.J. AMPA-induced lesions of the basal forebrain differentially affect cholinergic and non-cholinergic neurons: Lesion assessment using quantitative in situ hybridization histochemistry. European Journal of Neuroscience. 7:1995;1012-1021.
108. Palmer A.M., DeKosky S.T. Monoamine neurons in aging and Alzheimer's disease. Journal of Neural Transmission, General Section. 91:1993;135-159.
109. Palmer A.M., Francis P.T., Benton J.S., Sims N.R., Mann D.M., Neary D., Snowden J.S., Bowen D.M. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. Journal of Neurochemistry. 48:1987;8-15.
110. Palmer A.M., Wilcock G.K., Esiri M.M., Francis P.T., Bowen D.M. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Research. 401:1987;231-238.
111. Passani M.B., Cangioli I., Baldi E., Bucherelli C., Mannaioni P.F., Blandina P. Histamine H3 receptor-mediated impairment of contextual fear conditioning and in-vivo inhibition of cholinergic transmission in the rat basolateral amygdala. European Journal of Neuroscience. 14:2001;1522-1532.
112. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Brazilian Medical Journal. 2:1978;1457-1459.
113. Pizzo D.P., Thal L.J., Winkler J. Mnemonic deficits in animals depend upon the degree of cholinergic deficit and task complexity. Experimental Neurology. 177:2002;292-305.
114. Platt C.E., Wickens D.D. The effects of anticholinesterase agents upon animal behavior: The effects of a subcutaneous injection of di-isopropyl fluorophosphates on the retention of a maze habit by the albino rat. American Psychologist. 5:1950;254.
115. Power A.E., McGaugh J.L. Phthalic acid amygdalopetal lesion of the nucleus basalis magnocellularis induces reversible memory deficits in rats. Neurobiology of Learning and Memory. 77:2002;372-388.
116. Power A.E., McGaugh J.L. Cholinergic activation of the basolateral amygdala regulates unlearned freezing behavior in rats. Behavioral Brain Research. 134:2002;307-315.
117. Power A.E., McIntyre C.K., Litmanovich A., McGaugh J.L. Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors. Behavioural Pharmacology. 14:2003;207-213.
118. Power A.E., Roozendaal B., McGaugh J.L. Glucocorticoid enhancement of memory consolidation in the rat is blocked by muscarinic receptor antagonism in the basolateral amygdala. European Journal of Neuroscience. 12:2000;3481-3487.
119. Power A.E., Thal L.J., McGaugh J.L. Lesions of the nucleus basalis magnocellularis induced by 192 IgG-saporin block memory enhancement with posttraining norepinephrine in the basolateral amygdala. Proceedings of the National Academy of Sciences of the United States of America. 99:2002;2315-2319.
120. Prado-Alcala R.A., Cruz-Morales S.E., Lopez-Miro F.A. Differential effects of cholinergic blockade of anterior and posterior caudate nucleus on avoidance behaviors. Neuroscience Letters. 18:1980;339-345.
121. Quirarte G., Salado-Castillo R., Prado-Alcalá R.A. Involvement of cholinergic activity of the caudate-putamen in memory consolidation: A mapping study. European Neuropsychopharmacology. 4:1994;423-424.
122. Ragozzino M., Unick K., Gold P. Hippocampal acetylcholine release during memory testing in rats: Augmentation by glucose. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;4693-4698.
123. Ramírez-Lugo L., Miranda M.I., Escobar M.L., Espinosa E., Bermúdez-Rattoni F. The role of cortical cholinergic pre- and post-synaptic receptors in taste memory formation. Neurobiology of Learning and Memory. 79:2003;184-193.
124. Rasmusson D., Clow K., Szerb J. Modification of neocortical acetylcholine release and electroencephalogram desynchronization due to brainstem stimulation by drugs applied to the basal forebrain. Neuroscience. 60:1994;665-677.
125. Ridley R.M., Barefoot H.C., Maclean C.J., Pugh P., Baker H.F. Different effects on learning ability after injection of the cholinergic immunotoxin ME20.4IgG-saporin into the diagonal band of Broca, basal nucleus of Meynert, or both in monkeys. Behavioral Neuroscience. 113:1999;303-315.
126. Ridley R.M., Pugh P., Maclean C.J., Baker H.F. Severe learning impairment caused by combined immunotoxic lesion of the cholinergic projections to the cortex and hippocampus in monkeys. Brain Research. 836:1999;120-138.
127. Riekkinen P. Jr., Kuitunen J., Riekkinen M. Effects of scopolamine infusions into the anterior and posterior cingulate on passive avoidance and water maze navigation. Brain Research. 685:1995;46-54.
128. Robbins T.W., Everitt B.J., Marston H.M., Wilkinson J., Jones G.H., Page K.J. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: Further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behavioral Brain Research. 35:1989;221-240.
129. Roesler R., Roozendaal B., McGaugh J.L. Basolateral amygdala lesions block the memory-enhancing effect of 8-Br-cAMP infused into the entorhinal cortex of rats after training. European Journal of Neuroscience. 15:2002;905-910.
130. Roozendaal B., Nguyen B.T., Power A.E., McGaugh J.L. Basolateral amygdala noradrenergic influence enables enhancement of memory consolidation induced by hippocampal glucocorticoid receptor activation. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;11642-11647.
131. Rosat R., Da-Silva R.C., Zanatta M.S., Medina J.H., Izquierdo I. Memory consolidation of a habituation task: Role of N-methyl-D-aspartate, cholinergic muscarinic and GABA-A receptors in different brain regions. Brazilian Journal of Medical and Biological Research. 25:1992;267-273.
132. Rudy J.W. Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning. Neurobiology of Learning and Memory. 65:1996;73-81.
133. Russell R.W. Drugs as tools in behavioral research. Uhr L., Miller J.G. Drugs and behavior. 1960;Wiley, New York.
134. Salinas J.A., Introini-Collison I.B., Dalmaz C., McGaugh J.L. Posttraining intraamygdala infusions of oxotremorine and propranolol modulate storage of memory for reductions in reward magnitude. Neurobiology of Learning and Memory. 68:1997;51-59.
135. Schroeder J.P., Packard M.G. Posttraining intra-basolateral amygdala scopolamine impairs food- and amphetamine-induced conditioned place preferences. Behavioral Neuroscience. 116:2002;922-927.
136. See R.E., Fuchs R.A., Ledford C.C., McLaughlin J. Drug addiction, relapse, and the amygdala. Shinnick-Gallagher P., Pitkanen A., Shekhar A., Cahill L. The amygdala in brain function: Basic and clinical approaches. Annals of the New York Academy of Sciences. Vol. 985:2003;1-21.
137. See R.E., McLaughlin J., Fuchs R.A. Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats. Neuroscience. 117:2003;477-483.
138. Segal M., Auerbach J. Muscarinic receptors involved in hippocampal plasticity. Life Sciences. 60:1997;1085-1091.
139. Segal M. Acetylcholine enhances NMDA-evoked calcium rise in hippocampal neurons. Brain Research. 587:1992;83-87.
140. Setlow B., McGaugh J.L. Involvement of the posteroventral caudate-putamen in memory consolidation in the Morris water maze. Neurobiology of Learning and Memory. 71:1999;240-247.
141. Setlow B., Roozendaal B., McGaugh J.L. Involvement of a basolateral amygdala complex-nucleus accumbens pathway in glucocorticoid-induced modulation of memory consolidation. European Journal of Neuroscience. 12:2000;367-375.
142. Sokolov M., Kleschevnikov A. Atropine suppresses associative LTP in the CA1 region of rat hippocampal slices. Brain Research. 672:1995;281-284.
143. Souza M.M., Mello e Souza T., Vinade E.R., Rodrigues C., Choi H.K., Dedavid e Silva T.L., Medina J.H., Izquierdo I. Effects of posttraining treatments in the posterior cingulate cortex on short- and long-term memory for inhibitory avoidance in rats. Neurobiology of Learning and Memory. 77:2002;202-210.
144. Stratton L.O., Petrinovich L.F. Posttrial injections of an anticholinesterase druge on maze learning in two strains of rats. Psychopharmacologia. 5:1963;47-54.
145. Tomaz C., Dickinson-Anson H., McGaugh J.L., Souza-Silva M.A., Viana M.B., Graeff F.G. Localization in the amygdala of the amnestic action of diazepam on emotional memory. Behavioral Brain Research. 58:1993;99-105.
146. Tomlinson B.E., Irving D., Blessed G. Cell loss in the locus coeruleus in senile dementia of Alzheimer type. Journal of the Neurological Sciences. 49:1981;419-428.
147. Toumane A., Durkin T., Marighetto A., Galey D., Jaffard R. Differential hippocampal and cortical cholinergic activation during the acquisition, retention, reversal and extinction of a spatial discrimination in an 8-arm radial maze by mice. Behavioural Brain Research. 30:1988;225-234.
148. Vale-Martínez A., Baxter M.G., Eichenbaum H. Selective lesions of basal forebrain cholinergic neurons produce anterograde and retrograde deficits in a social transmission of food preference task in rats. European Journal of Neuroscience. 16:2002;983-998.
149. Vazdarjanova A., McGaugh J.L. Basolateral amygdala is involved in modulating consolidation of memory for classical fear conditioning. Journal of Neuroscience. 19:1999;6615-6622.
150. Waite J.J., Thal L.J. Lesions of the cholinergic nucleui in the rat basal forebrain: Excitotoxins v. an immunotoxin. Life Sciences. 58:1996;1947-1953.
151. Waite J.J., Chen A.D., Wardlow M.L., Wiley R.G., Lappi D.A., Thal L.J. 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar purkinje cells. Neuroscience. 65:1995;463-476.
152. Walz R., Roesler R., Barros D.M., de Souza M.M., Rodrigues C., Sant'Anna M.K., Quevedo J., Choi H.K., Neto W.P., DeDavid e Silva T.L., Medina J.H., Izquierdo I. Effects of post-training infusions of a mitogen-activated protein kinase kinase inhibitor into the hippocampus or entorhinal cortex on short- and long-term retention of inhibitory avoidance. Behavioural Pharmacology. 10:1999;723-730.
153. Walz R., Roesler R., Quevedo J., Rockenbach I.C., Amaral O.B., Vianna M.R., Lenz G., Medina J.H., Izquierdo I. Dose-dependent impairment of inhibitory avoidance retention in rats by immediate post-training infusion of a mitogen-activated protein kinase kinase inhibitor into cortical structures. Behavioral Brain Researchs. 105:1999;219-223.
154. Walz R., Roesler R., Quevedo J., Sant'Anna M.K., Madruga M., Rodrigues C., Gottfried C., Medina J.H., Izquierdo I. Time-dependent impairment of inhibitory avoidance retention in rats by posttraining infusion of a mitogen-activated protein kinase kinase inhibitor into cortical and limbic structures. Neurobiology of Learning and Memory. 73:2000;11-20.
155. Weinberger N. Dynamic regulation of receptive fields and maps in the adult sensory cortex. Annual Review of Neuroscience. 18:1995;129-158.
156. Weinberger N. Physiological memory in primary auditory cortex: Characteristics and mechanisms. Neurobiology of Learning and Memory. 70:1998;226-251. Wenk G.L. The nucleus basalis magnocellularis cholinergic system: One hundred years of progress. Neurobiology of Learning and Memory. 67:1997;85-95.
157. Wenk G.L. The nucleus basalis magnocellularis cholinergic system: One hundred years of progress. Neurobiology of Learning and Memory. 67:1997;85-95.
158. Wenk G.L., Stoehr J.D., Quintana G., Mobley S., Wiley R.G. Behavioral, biochemical, histological and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. Journal of Neuroscience. 14:1994;5986-5995.
159. Whitehouse J. Effects of atropine on discrimination learning in the rat. Journal of Comparative Physiology and Psychology. 57:1964;13-21.
160. Woolf N.J., Milov A.M., Schweitzer E.S., Roghani A. Elevation of nerve growth factor and antisense knockdown of TrkA receptor during contextual memory consolidation. Journal of Neuroscience. 21:2001;1047-1055.
161. Wrenn C.C., Wiley R.G. The behavioral functions of the cholinergic basal forebrain: Lessons from 192 IgG-saporin. International Journal of Developmental Neuroscience. 16:1998;595-602. Wrenn C.C., Lappi D.A., Wiley R.G. Threshold relationship between lesion extent of the cholinergic basal forebrain in the rat and working memory impairment in the radial maze. Brain Research. 847:1999;284-298.
162. Wrenn C.C., Lappi D.A., Wiley R.G. Threshold relationship between lesion extent of the cholinergic basal forebrain in the rat and working memory impairment in the radial maze. Brain Research. 847:1999;284-298.
163. Xu M., Mizobe F., Yamamoto T., Kato T. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Brain Research. 495:1989;232-242.
164. Zhang Z.J., Berbos T.G., Wrenn C.C., Wiley R.G. Loss of nucelus basalis magnocellularis, but not septal, cholinergic neurons correlates with passive avoidance impairment in rats treated with 192-saporin. Neuroscience Letters. 203:1996;214-218.